Adicet Bio Inc (NASDAQ:ACET)
| 12.90 Delayed Data As of May 16 |  +1.07 / +9.04%Today’s Change | 6.25 Today|||52-Week Range 21.17 | -26.24% Year-to-Date |
Latest ACET News | Press Releases
| X4 Pharmaceuticals (XFOR) Reports Q1 Loss, Misses Revenue Estimates May 12 / Zacks.com - Paid Partner Content | Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q1 Loss, Tops Revenue Estimates May 10 / Zacks.com - Paid Partner Content |
| Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates May 11 / Zacks.com - Paid Partner Content | Pliant Therapeutics, Inc. (PLRX) Reports Q1 Loss, Lags Revenue Estimates May 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 11.83 |
| Today’s open | 11.67 |
| Day’s range | 11.63 - 13.09 |
| Volume | 399,417 |
| Average volume (3 months) | 366,762 |
| Market cap | $472.0M |
Data as of 05/16/2022
Growth & Valuation
| Earnings growth (last year) | +60.02% |
| Earnings growth (this year) | +39.30% |
| Earnings growth (next 5 years) | +11.78% |
| Revenue growth (last year) | -45.65% |
| P/E ratio | -- |
| Price/Sales | 55.64 |
| Price/Book | 1.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCYCBicycle Therapeutics... | 0.00 | 0.00% |
| GERNGeron Corp | 0.00 | 0.00% |
| SIGASIGA Technologies In... | -0.10 | -1.34% |
| ANIPANI Pharmaceuticals ... | 0.00 | 0.00% |
Data as of 05/16/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $9.7M |
| Annual profit (last year) | -$62.0M |
| Net profit margin | -637.19% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
